🧵 1/3 Bristol Myers Squibb Co ($BMY) INSIDER BUY 💊
EVP, Chief Medical Officer Samit Hirawat purchased 4,250 shares at $47.58 per share, investing $202,215.
"Pittance of insider buys, almost an insult to shareholders who have been suffering for a decade with nothing to show but a paltry increase in dividends. Bristol-Myers Squibb pays an annual dividend of $2.48 per share, with a dividend yield of 5.35%. BMY has grown its dividend for 17 consecutive years, with an average annual increase of
2.08%. The company currently pays out 92.88% of its earnings and 50.69% of its cash flow as dividends."
Bristol-Myers Squibb focuses on discovering, developing, and delivering transformational medicines for patients with serious conditions, primarily in oncology, hematology, neuroscience, and other therapeutic areas.
Despite the modest insider purchase, does BMY's high dividend yield make it worth considering as an income play in your portfolio? Or is management's lack of significant skin in
Insider Buying Week 05-09-25 Bargain Basement Week

Finally, a busy week. I can’t extrapolate anything about the general market from these buys, but it’s clear that some […]

The Insiders Fund